Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Confluent Surgical
company
About
Confluent Surgical develops products to address the need for surgical sealing and post-surgical adhesion prevention applications.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $23M
- Industries
- Health Care,Information Technology,Manufacturing
- Founded date
- Jan 1, 1998
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Confluent Surgical develops products to address the need for surgical sealing and post-surgical adhesion prevention applications.The company provides DuraSeal, an adjunct to sutured dural repair during cranial surgeries to provide watertight closure.The company was founded in 1998 and is headquartered in Waltham, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$43M
Confluent Surgical has raised a total of
$43M
in funding over 2 rounds. Their latest funding was raised on
Mar 31, 2005 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 31, 2005 | Series D | $23M | 1 | — | — | Detail |
| Jun 25, 2002 | Series C | $20M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Confluent Surgical is funded by 1 investors.
Cross Atlantic Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Cross Atlantic Partners
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
